The company is trying to develop a one-time treatment for forms of heart disease that afflict more than 1 million people in ...
In a report released on January 9, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...
In a report released today, James Gordon from J.P. Morgan reiterated a Sell rating on GlaxoSmithKline (GSK – Research Report). The company’s ...
In a footnote of his opinion, Judge Joshua Roberts wrote, “A more cynical view of the circumstances is that plaintiffs’ ...
Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.
TORONTO, ON / ACCESSWIRE / January 10, 2025 / ARway.ai("ARway" or the "Company") (CSE:ARWY)(OTCQB:ARWYF)(FSE:E65) is an AI ...
Compounds that enhance enzyme activity show promise for cellular rejuvenation and treating age-related diseases. However, ...
Moderna stock was on track to see a weekly gain of over 20% as of Wednesday following the first reported bird flu death in the US.
Drugmaker GSK said, a stamp has been released by India Post to commemorate its 100 years in India. The ₹5 denomination stamp ...
The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback